Pharmaceuticals · Nov 19, 2026
Tirzepatide Attenuates Cortical Inflammatory and Neuronal Alterations in Diabetic Rats: Associations with PI3K/AKT Phosphorylation and Conditioned Fear Responses
By Lei M, Zhang Y, Chen M et al.
Background/Objectives: Tirzepatide lowers blood glucose, but its effects on diabetes-associated neurological dysfunction remain incompletely characterized. We examined conditioned fear responses and accompanying prefrontal cortical alterations in diabetic rats. Methods: Male Sprague Dawley rats with diabetes induced by a high-fat diet and streptozotocin received tirzepatide (1.35 mg/kg intraperitoneally, twice weekly) for 10 weeks. Metabolic and behavioral assessments included eight rats per group. Neuronal morphology, synapse-associated proteins, tau phosphorylation, inflammatory cytokines, PI3K/AKT phosphorylation, and autophagy-related proteins were examined in prefrontal cortical tissue. Results: Tirzepatide treatment was associated with improved glycemic control and oral glucose tolerance. The insulin-tolerance-test area under the curve did not differ significantly between treated and untreated diabetic rats (adjusted p = 0.0993). Treated diabetic rats showed higher freezing at 96 h (adjusted p = 0.0017), although the group-by-time interaction was not significant (p = 0.1308). Treatment was associated with fewer neurons showing degeneration-like morphology, higher PSD95 and SYT1 abundance, and lower tau phosphorylation at Thr205 and Ser404. Prefrontal cortical TNF-α, IL-6, and IL-1β expression decreased. Prefrontal cortical TNF-α and IL-1β mRNA levels and protein concentrations of TNF-α, IL-6, and IL-1β were lower following tirzepatide treatment, whereas the reduction in IL-6 mRNA was not statistically significant. PI3K/AKT phosphorylation and the abundance of autophagy-related proteins were also altered. Conclusions: The findings link tirzepatide treatment to metabolic, behavioral, inflammatory, and neuronal changes in diabetic rats. They do not establish PI3K/AKT causality, restored autophagic flux, or restored long-term memory. Direct central effects cannot be separated from the consequences of improved systemic metabolism. Initial conditioning differences and the absence of independent locomotor and shock-sensitivity assessments limit the behavioral interpretation. Nissl morphology and synaptic protein abundance do not independently establish neuronal viability or improved synaptic function.